Physician profile
Marshall Huang
NPI 1427546779
$6,059.55
in general payments reported to CMS, 2019-2025
19 companies · $1,244 in 2025
The $1,244 reported for 2025 was more than what 82% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.50 · 2020: $20.51 · 2021: $613 · 2022: $578 · 2023: $2,148 · 2024: $1,435 · 2025: $1,244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,170 · Charitable Contribution: $1,657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,169.85 |
| Charitable Contribution | $1,656.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microsurgical Technology, INC. | $1,656.51 | 2023 | |
| Alcon Vision LLC | $1,389.81 | 2019-2025 | Hydrus Microstent, Rocklatan, Clareon |
| Sight Sciences, INC. | $869.35 | 2021-2025 | Omni Surgical System, Sion Surgical Instrument |
| Glaukos Corporation | $788.11 | 2021-2025 | Istent Infinite, Idosetr, Idose |
| Abbvie INC. | $253.53 | 2024-2025 | |
| Bausch & Lomb Americas INC. | $187.28 | 2022-2025 | Vyzulta, Miebo |
| Allergan, INC. | $171.58 | 2021-2022 | |
| Oculus Surgical INC. | $161.56 | 2021 | |
| Astellas Pharma US INC | $124.12 | 2024 | Izervay |
| Aerie Pharmaceuticals, INC. | $101.77 | 2021 | |
| Rxsight INC | $80.74 | 2024-2025 | Light Adjustable Lens (Lal), Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd) |
| Rayner Intraocular Lenses Limited | $58.79 | 2025 | Omidria, Rayone Aspheric, Rayone Emv |
| New World Medical,INC. | $54.78 | 2024 | Streamline, Ahmed Glaucoma Valve, Kahook Dual Blade |
| Sun Pharmaceutical Industries INC. | $46.80 | 2024-2025 | |
| Carl Zeiss Meditec USA, INC. | $27.25 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $26.48 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $25.75 | 2021 | |
| Harrow Eye, LLC | $17.98 | 2025 | Triesence |
| Tarsus Pharmaceuticals, INC. | $17.36 | 2024 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marshall Huang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.